Programme - 24th Biennial International Congress on

Transkript

European and Mediterranean League
against Thrombotic Diseases
EMLTD
24
th
Biennial
International
Congress on Thrombosis
T
L
M
Istanbul, Turkey - May 4-7, 2016
HALIÇ CONGRESS CENTER
E
www.thrombosis2016.org
1
WELCOME
Dear Colleagues,
On behalf of the Congress Executive Board, the local Organizing Committee and
the Council of the European and Mediterranean League against Thrombotic
Diseases, it is with great pleasure and privilege to invite you to the 24th International
Congress on Thrombosis to be held in Istanbul, Turkey on May 4-7, 2016.
This will be the third ICT Congress held in Turkey. The first two were held in 1974 and
2008 by Prof. Dr. Orhan N. Ulutin who was a founding member of many international
organizations, including EMLTD and the Hemostasis and Thrombosis Congresses in Turkey.
The Scientific Programme of the upcoming Congress will cover topics ranging from various
fields of clinical and laboratory issues on thrombosis and related scientific issues. The Congress
will feature contemporary lecture topics, evidence-based hematology sessions, and satellite
symposia covering the latest developments on thrombotic diseases. The education program
of the Congress will strike a balance between the needs of both basic and clinical issues. We
took great care in designing a program that caters to the needs of younger attendees through
discussions that foster scientific exchange, presentations, awards and special social functions.
The cultural program also promises to be appealing, and will highlight Istanbul’s proud culture
and national heritage. Istanbul’s history dates back to the end of the 4th century B.C., and relics
from the Hellenic, Roman, Byzantine and Ottoman periods are scattered throughout the city.
The Hagia Sophia, Basilica Cistern, Blue Mosque, Grand Bazaar, Topkapı Palace and Turkish
Baths, all contribute to Istanbul’s unique experience as an open-air museum. You will have the
opportunity to discover Turkish music, art and architecture, enjoy delicious Turkish and Ottoman
cuisines, and experience worldrenowned Turkish hospitality. Istanbul’s unique geography at
the crossroads of Europe and Asia, allows the world “to meet where the continents meet”.
The Haliç Congress Center will be the venue for the Congress. The Haliç Congress
Center is ideally situated along the shores of the Golden Horn. The Center is easily
accessible from hotels and via public transportation to and from the entire city.
D
T
L
Once again, on behalf of the Executive Board of EMLTD and of the Organizing Committee, I
would like to invite you to the 24th International Congress on Thrombosis. I sincerely believe
that you will enjoy both the scientific and cultural aspects of the programme, and the pleasure
of spring time in Istanbul.
M
E
I look forward to personally welcoming you to Istanbul in May, 2016!
Ahmet Muzaffer Demir, M.D.
President of 24th International
Congress on Thrombosis
2
GENERAL INFORMATION
VENUE
Haliç Congress Center Istambul
Sutluce Mah. Karaagac Cad. No.19
34445 Beyoglu Istanbul, Turkey
BADGE
Each participant will receive a name badge upon check-in at the
Registration Desk. The badge will be considered as an official
meeting document and should be carried all the time in order to get
granted access to the meeting rooms.
REGISTRATION DESK
The registration desk is located in the Main Hall, next to the entrance
and it will be open on:
Wednesday
Thursday
Friday
Saturday
May 4th
May 5th
May 6th
May 7th
12:00 - 18:00
08:15 - 19:00
08:15 - 19:00
08:15 - 14:00
ELECTRONIC DEVICES
As a courtesy to your colleagues, we invite you to turn off or silence
all electronic devices during the educational, plenary sessions and
symposiums.
T
L
M
WI-FI
Internet access is available through WIFI connection.
CATERING FACILITIES
Lunch boxes will be served in the exhibitor area, at the time specified
in the programme. Coffee breaks will be also provided during the
Congress.
E
EMLTD
3
Committee
CONGRESS EXECUTIVE COMMITTEE
Ali Taher (Lebanon)
Ayşegül Ünüvar (Istanbul, Turkey)
President
Z. Tazi (Morocco)
Fikriye Uras (Istanbul, Turkey)
Ahmet Muzaffer Demir (Edirne, Turkey)
Iovtchо Boyanov Topalov (Bulgaria)
Ayşen Yarat (Istanbul, Turkey)
Vice-President
Anthi Travlou (Greece)
Bülent Zülfikar (Istanbul, Turkey)
Turgut Ulutin (Istanbul, Turkey)
Maria Teresa Santos (Spain)
Reyhan Küçükkaya (Istanbul, Turkey)
Turgut Ulutin (Turkey)
INTERNATIONAL ADVISORY COMMITTEE
Members
David Varon (Israel)
Essam Aboelnazar (Egypt)
Nejat Akar (Ankara, Turkey)
Eugene V. Roitman (Russia)
Juan José Badimon (USA)
Faik Altıntaş (Istanbul, Turkey)
Abdul Kareem Al Momen (Saudi Arabia)
Henri Bounameaux (Switzerland)
Birsen Ince (Istanbul, Turkey)
Ivo Elezovic (Serbia)
Benjamin Brenner (Israel)
Kaan Kavaklı (Izmir, Turkey)
Teresa Padró (Spain)
Harry R. Büller (The Netherlands) Mehmet Kurtoğlu (Istanbul, Turkey)
Marco Cattaneo (Italy)
Şermin Tetik (Istanbul, Turkey)
LOCAL ORGANIZING COMMITTEE
S. Coccheri (Italy) Gül Öngen (Istanbul, Turkey)
Cafer Adıgüzel (Istanbul, Turkey)
Ola E. Dahl (Norway)
Zeki Öngen (Istanbul, Turkey)
Can Balkan (Izmir, Turkey)
Bjorn Dahlback (Sweden) Ergül Berber (Istanbul, Turkey)
Ismaïl Elalamy (France) EUROPEAN AND MEDITERRANEAN LEAGUE
M. Cem Ar (Istanbul, Turkey)
Jawed Fareed (USA) AGAINST THROMBOTIC DISEASES
Veysel Sabri Hançer (Istanbul, Turkey)
Andreas Greinacher (Germany) President
Zühre Kaya (Ankara, Turkey)
David A. Lane (United Kingdom)
Lina Badimon (Spain)
Ilhan Onaran (Istanbul, Turkey)
Marcel Levi (The Netherlands) President: Former President
Gülnihal Özdemir (Istanbul, Turkey)
Christos Liapis (Greece) Jean-François Schved (France)
Elif Uğur Ümit (Edirne, Turkey)
Gregory YH Lip (United Kingdom) Jose Lopez (USA)
General Secretary
María Teresa Santos (Spain)
NATIONAL ADVISORY COMMITTEES
Abdul Kareem Al Momen (Saudi Arabia)
Members
Bülent Antmen (Adana, Turkey)
Nevine Kassim (Egypt)
Ismaïl Elalamy (France)
Zafer Başlar (Istanbul, Turkey)
Nigel Key (USA)
Paolo Prandoni (Italy)
Cengiz Beyan (Ankara, Turkey)
Pier Mannucci (Italy)
David Varon (Israel)
Ali Zahit Bolaman (Aydın, Turkey)
Claire McLintock (USA) Kürşat Bozkurt (Istanbul, Turkey)
Danijela Mikovic (SERBIA)
COUNTRY COUNCILORS
Tiraje Celkan (Istanbul, Turkey)
Joao Morais (Portugal)
Cherif Abdelkhirane (Morocco)
Cansun Demir (Istanbul, Turkey)
James Morrissey (USA) Mehmet Nejat Akar (Turkey)
Fatih Demirkan (Izmir, Turkey)
Lina Badimon (Spain)
Yeşim Erbil (Istanbul, Turkey)
Ana Bronic (Croatia)
Bülent Erdemli (Ankara, Turkey)
Manuel Campos (Portugal)
Nil Güler (Samsun, Turkey)
Jean-François Schved (France)
Ibrahim C. Haznedaroğlu (Ankara, Turkey)
Luis Manuel Cunha-Ribeiro (Portugal)
Necip Ilhan (Elazığ, Turkey)
Maria Benedetta Donati (Italy)
Ismaïl Elalamy (France)
Sami Guermazi (Tunisia)
Antonios Hatzizacharias (Greece)
Nevine Kassim (Egypt)
Andrew Nicolaides (Cyprus)
Uri Seligsohn (Israel)
Matija Kozak (Slovenia)
4
D
T
L
M
E
Nil Molinas (Istanbul, Turkey)
Hale Ören (Izmir, Turkey)
Gülsüm Özet (Ankara, Turkey)
Fahir Özkalemkaş (Bursa, Turkey)
Mehmet Sönmez (Trabzon, Turkey)
Teoman Soysal (Istanbul, Turkey)
Mahmut Tobü (Izmir, Turkey)
Lale Tokgözoğlu (Ankara, Turkey)
Levent Ündar (Antalya, Turkey)
Per Morten Sandset (Sweden)
Yukio Ozaki (Japan)
Paolo Prandoni (Italy) P H Reitsma (The Netherlands) Suely Meireles Rezende (Brazil) Frits Rosendaal (The Netherlands) M.T. Santos (Spain) Jean-François Schved (France)
Matija Kozak (Slovenia)
Svetlana M Strukova (Russia)
Ali Taher (Lebanon) David Varon (Israel)
Jaenine Walenga (USA)
Steve Watson (United Kingdom)
Jeffrey Weitz (Canada)
SPEAKERS
Mehmet Nejat Akar
TOBB, Turkey
Henri Bounameaux
University of Geneva, Switzerland
David Varon
Hadassah-Hebrew University Medical Center, Israel
Hasan Yazıcı
University of Istanbul, Turkey
Maria Graciela Pedreira
Hospital de Clínicas Udelar, Uruguay
Ingrid Pabinger
Medical University of Vienna, Austria
Zeki Ongen
Istanbul University, Turkey
María Teresa Santos
University Hospital La Fe, Spain
Joan Montaner Villalonga
VHIR, Spain
Ali Al-Hakim
FDA, USA
Charles Marc Samama
Cochin University Hospital, France
Yesim Dargaud
Hôpital Cardiologique Louis Pradel, France
Pier Mannuccio Mannucci
IRCCS, Italy
Nigel Key
UNC Hemophilia & Thrombosis Center, USA
Christos D. Liapis
Athens University Medical School, Greece
Lina Badimon
CSIC-ICCC, Spain
Raffaele de Caterina
Institute of Cardiology, Italy
Ismael Elalamy
Hôpitaux Universitaires Paris, France
Athanasios D. Giannoukas
University Hospital of Larissa, Greece
Igor Bokarev
I. M. Sechenov First Moscow State Medical University,
Russia
Maria Benedetta Donati
Department of Epidemiology and Prevention, Italy
Mehmet Hamdi Kurtoğlu
Jean-François Schved
CHU Hospital, France
Reyhan Kucukkaya
Istanbul Bilim Universitesi, Turkey
Hugo Ten Cate
Maastricht University Medical Center, The Netherlands
Ola E. Dahl
Innlandet Hospital Trust and Thrombosis Research
Institute, Norway
Muhlis Cem Ar
John H. Griffin
The Scripps Research Institute, USA
Bagirath Gangadharam
Baxalta Innovations GmbH, Austria
Antonio Moscardó
University Hospital La Fe, Spain
Mehmet Ali Özcan
Dokuz Eylül University, Turkey
Jawed Fareed
Loyola University Chicago, USA
Yiming Yao
Ronnsi Pharma Co Ltd., JiangSu, China
Shaker Mousa
The Pharmaceutical Research Institute at Albany,
Albany College of Pharmacy and Health Sciences,
Rensselaer, New York, USA
Teresa Padró
CSIC-ICCC, IIBSantPau, Spain
Uluc Yis
Dokuz Eylul University, Turkey
Sule Unal
Hacettepe University, Turkey
T
L
M
Doruk Erkan
Hospital for Special Surgery, USA
Essam Aboelnazar
UQU University, Saudi Arabia
Emmanuel Favaloro
Institute of Clinical Pathology and Medical Research,
ICPMR, Australia
E
Peter Brønnum Nielsen
Aalborg University, Denmark
Oktay Ozdemir
Yorum Health Consulting Ltd., Turkey
Gemma Vilahur
CSIC-ICCC, IIBSantPau, Spain
Thomas Renné
Karolinska Institute and Universitz Hospital, Sweden
Aysegul Ünüvar
Can Balkan
Vanessa Roldán
Hospital Universitario Morales Meseguer, Spain
Muhlis Cem Ar
Cerrahpaşa University, Turkey
Mustafa Nuri Yenerel
Mehmet Ali Özcan
Dokuz Eylül University, Turkey
Massimo Iacobelli
Consultant on Pharmaceutical Strategic Planning and
Development, Loyola University Chicago, Chicago,
USA
Frits Rosendaal
University Medical Center, The Netherlands
Mohammad Faranoush
Hematologist and Oncologist, Iran University of
Medical Sciences, Tehran, Iran
Ergul Berber
Arel University, Istanbul
Danijela Mikovic
Blood Transfusion Institute of Serbia
Paolo Prandoni
University of Padova, Italy
Lorenzo Montrasio
AIFA, Italy
Marcel M. Levi
University of Amsterdam, The Netherlands
Johannes Thaler
Medical University of Vienna, Austria
Kaan Kavakli
Ege University, Turkey
Inam Hussain
Consultant Hemostasis Reasearch Lavoratory, Loyola
University, USA
Evi Kabdiki
Ealing Hospital, London, England
Nilgün Sayinalp
Hacettepe University, Ankara, Turkey
İpek Kıvılcım Oğuzülgen
Gazi University School of Medicine, Ankara, Turkey
5
CHAIRMEN
Ahmet Muzaffer Demir
Trakya University, Edirne, Turkey
Lina Badimon
Cardiovascular Research Center, CSIC-ICCC.
Barcelona, Spain
Sengun Ulutin
Mehmet Hamdi Kurtoglu
Shaker Mousa
The Pharmaceutical Research Institute at Albany,
Albany College of Pharmacy and Health Sciences,
Rensselaer, New York, USA
Zeki Öngen
Jacqueline Conard
Hotel-Dieu, Paris, France
Charles Marc Samama
Cochin University Hospital, Paris, France
Vicente Vicente
Centro Hemodonación, Murcia, Spain
María Teresa Santos
University Hospital La Fe, Valencia, Spain
Nevine Kassim
Ain Shams University, Faculty of Medicine. Heliopolis,
Cairo. Egypt
Erdal Aslım
Acıbadem Hospital, Istanbul,Turkey
Mehmet Ağırbaşlı
Medeniyet University, Turkey
Hasan Yazıcı
Evgeny Roitman
Pigorov Russian National Research Medical University,
Russia
Meliha Nalcacı
Birsen Ince
Faik Altıntaş
Yeditepe University, Turkey
Cafer Adiguzel
Medical Parc Hospital, Istanbul, Turkey
Yeşim Erbil
Osman Bülent Zülfikar
Kürsat Bozkurt
Gül Öngen
Lale Tokgözoglu
Hacettepe University, Turkey
Nilgün Sayınalp
Hacettepe University, Ankara, Turkey
Alexandros Tselepis
University of Ioannina, Greece
Ali Al Hakim
FDA, USA
Tazi Mezalek Zoubida
Ibn Sina Hospital, Morocco
Mahmut Töbü
Ege University, Turkey
Mustafa Nuri Yenerel
Marco Guerrini
Istituo di Ricerche Chimiche e Bio chimiche
6-Ronzoni, Italy
Sergio Coccheri
University of Bologna, Italy
Kaan Kavakli
Ege University Children Hospital, Turkey
Turgut Ulutin
María Graciela Pedreira
Hospital de Clínicas Udelar, Uruguay
Jawed Fareed
Loyola University Chicago, USA
Nehmet Nejat Akar
TOBB, Turkey
Zafer Baslar
Tulin Tiraje Celkan
Cerrahpasa Medical Faculty, Istanbul, Turkey
Ana Bronic
Traumatology Clinic, Clinical Hospital Centre “Sestre
Milosrdnice”, Zagreb, Croatia
D
T
L
M
E
Lorenzo Montrasio
AIFA, Italy
Grigoris Gerotziafas
Hôpitaux Universitaires Est Parisien, Faculté de
médecine Pierre et Marie Curie, Université Paris VI.
France
Ayşegül Ünüvar
Nigel Key
UNC Hemophilia & Thrombosis Center, USA
Emin Kansu
ISH Chair of Council, Turkey
6
Abdulkareem Mohammed Almomen
College of Medicine & KKUH, King Saud University,
Saudi Arabia
Hale Ören
Dokuz Eylül University, Izmir, Turkey
Paolo Prandoni
Clinica Medica 2, University of Padova, Italy
SCIENTIFIC
PROGRAMME
T
L
M
E
7
WEDNESDAY, MAY 4 2016
Eyüp Auditorium
12:00 - 18:00
Registration
14:00 - 15:00
Opening Lectures. Prof. Dr. Orhan N. Ulutin Session I Chairs: Ahmet Muzaffer Demir (Turkey), Lina Badimon (Spain)
14:00 14:30
Discovery of FV Leiden Mutation in Urartu Ruins (BC 1000) in Van- Turkey
Mehmet Nejat Akar (TOBB, Turkey)
14:30 15:00
Behçet’s Disease, Vascular Complications and Thrombosis
Hasan Yazıcı (University of Istanbul, Turkey)
15:00 - 15:30
Coffee Break
15:30 - 17:00
Opening Lectures. Prof. Dr. Orhan N. Ulutin Session II
Chairs: Sengun Ulutin (Turkey), Emin Kansu (Turkey), Jawed Fareed (USA)
15:30 16:00
Stroke and Bleeding Risk Stratification in Atrial Fibrilation: from Guidelines to Clinical Practice
Zeki Ongen (Istanbul University, Turkey)
16:00 16:30
Heparin Centennial. A Century of scientific and clinical progress
Jawed Fareed
16:3017:00
Aging is a Global Problem: Focus on Thrombosis and Haemostasis
Pier Mannuccio Mannucci (IRCCS, Italy)
17:00 - 18:00
8
Satellite Symposia
Essentials and New Approaches in Hemophilia B Treatment
Chair: Ayşegül Ünüvar, (Turkey)
17:00 17:30
Physiology of FIX and Bleeding Pattern Pier Mannuccio Mannucci, Italy
17:30 18:00
Switch to BeneFIX from pdFIX Products and Once Weekly Prophylactic Treatment
Kaan Kavaklı, Turkey
18:00 - 18:15
Opening Ceremony
Chairs: Lina Badimon (Spain), Ahmet Muzaffer Demir, (Turkey)
18:15 - 19:15
Dance Show
Polyphonic Chorus
M
E
D
T
L
THURSDAY, MAY 5 2016
08:30 - 09:30
Fener Auditorium
Eyüp Auditorium
Prof. Dr. Meyer-Michel Samama Session.
Heparin Induced Thrombocytopenia
Chairs: Jacqueline Conard( France)
Prof. Dr. Jose Antonio Iriarte Session.
Atherosclerosis and Risk Factors
Chairs: Vicente Vicente (Spain),
María Teresa Santos (Spain)
Current Concepts in atherosclerosis and its risk factors
Lina Badimon (CSIC-ICCC, Spain)
08:30 09:00
Pharmacology of Heparins and Heparinomimetics
Jawed Fareed, (Loyola University Chicago, USA)
09:00 09:30
Pathogenesis and Treatment of HIT in 2016
Grigoris T Gerotziafas (Hôpitaux Universitaires Paris, France)
09:40 - 10:40
Oral Communications
Eyüp Auditorium
Fener Auditorium
OC-1-TH
OC-3-TH
OC-1-TH VENOUS THROMBOEMBOLISM (Eyüp Auditorium)
Chairs: Paolo Prandoni (Italy), Mahmut Töbü (Turkey)
C-0057
HIGH PREVALENCE OF PULMONARY EMBOLISM IN PATIENTS HOSPITALIZED FOR SYNCOPE
Paolo Prandoni, Anthonie Wa Lensing, Martin H Prins, Maurizio Ciammaichella, Marica Perlati, Nicola Mumoli, Eugenio Bucherini,
Adriana Visonà, Carlo Bova, Davide Imberti, Stefano Campostrini, Sofia Barbar
C-0083
INCIDENCE OF HOSPITAL-ACQUIRED VENOUS THROMBOEMBOLIC DISEASE AMONG CLINICAL AND SURGICAL INPATIENTS
Maria Lourdes Posadas-Martinez, María Florencia Grande-Ratti, Jimena Vicens, Fernán González Bernaldo De Quirós, Fernando
Javier Vázquez, Diego Giunta
C-0110
EFFECTS OF INFERIOR VENA CAVA FILTER IN PATIENTS WITH THROMBOEMBOLIC RECURRENCES ON ANTICOAGULANT
THERAPY
Meritxell Mellado Joan, José Ignacio Pijoan, David Jiménez, Alfonso Muriel, Drahomir Aujesky, Laurent Bertoletti, Herve Decousus,
Silvy Laporte, Albert Clará, Roger Yusen, Manel Monreal, Riete Investigators
C-0324
ANALYSIS OF HEPARIN INDUCED THROMBOCYTOPENIA SCREENING TESTS IN CRITICAL CARE UNITS AT KING FAISAL
SPECIALIZED HOSPITAL AND RESEARCH CENTER
M.G. Jamil, Osamah Khojah, K. Maghrabi, S. Barri, N. Salahuddin, R. Amin, I. Khoja, T. Owaidah
C-0058
A PROSPECTIVE ALGORITHM INCORPORATING LIMITED AND WHOLE-LEG ASSESSMENT OF THE DEEP VENOUS SYSTEM IN
SYMPTOMATIC OUTPATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (THE PALLADIO STUDY)
Walter Ageno, Giuseppe Camporese, Nicoletta Riva, Matteo Iotti, Eugenio Bucherini, Marc Righini, Pieter Kamphuisen, Peter
Verhamme, James Douketis, Chiara Tonello, Paolo Prandoni
C-0245
GUIDELINE ADHERENCE OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANT THERAPY : RESULTS FROM RAMSES
STUDY
Ozcan Basaran, Volkan Dogan, Murat Biteker, Osman Beton, Mehmet Tekinalp, Ismail Bolat, Onur Tasar, Macit Kalcik,
Ezgi Kalaycioglu, Ahmet Cagri Aykan, Ozgen Safak, Mehmet Yaman, Sinan Inci, Bernas Altintas, Sedat Kalkan, Fatma
Karadeniz, Ibrahim Altun, Mustafa Ozcan Soylu
T
L
M
E
OC-3-TH DIAGNOSTIC AND LABORATORY METHODS (Fener Auditorium)
Chairs: Yesim Dargaud, Turkey; Alexandros Tselepis, (Greece)
C-0333
SENSITIVITY OF LOCAL DRVTT SCREEN AND CONFIRM REAGENTS TO RIVAROXABAN AND APIXABAN
Desiree Coen Herak
C-0374
DIFFERENCES IN THROMBIN GENERATION MARKERS AT BASELINE IN PATIENTS WITH SEPSIS ASSOCIATED COAGULOPATHIES
Debra Hoppensteadt, Amanda Walborn, Daniel Kahn, Mark Williams, Jawed Fareed
C-0153
EVALUATION OF THROMBOELASTOGRAPHY (TEG) IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASM: PLATELET COUNT
>600 (X109/L) ASSOCIATED WITH PROTHROMBOTIC PARAMETERS
Cheryl Ng, Carole Smith, Lachlan Hayes, Andrew Grigg, Harshal Nandurkar, Prahlad Ho
9
10:40 - 11:15
C-0343
DOXORUBICIN-INDUCED MDR1/P-GP IN MCF7 BREAST CANCER CELLS WAS ASSOCIATED WITH TISSUE FACTOR
OVEREXPRESSION AND THROMBIN GENERATION
Khaterchi Amir, Karroum Asma, Mbemba Elisabeth, Rousseau Aurelie, Van Dreden Patrick, Gkalea Vassiliki, Elalamy Ismail, Hatmi
Mohamed, Gerotziafas Grigorios
C-0350
ASSESSEMENT OF QUALITY OF ANTICOAGULATION WITH VKA IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
Helena Cruz Gomes, Fátima Correia, Luciana Gonçalves, Carla Monteiro, Manuela Carvalho, Beatriz Delgado, Carmo Koch, Graça
Oliveira
C-0136
EXOSOMAL MICRORNA SIGNATURE PREDICTS FUTURE ISCHEMIC EVENTS IN HIGH CARDIOVASCULAR RISK PATIENTS
Rosa Suades, Teresa Padro, Sandra Camino, Rodrigo Alonso, Pedro Mata, Lina Badimon
Poster Viewing - Coffee Break
11:15 - 12:45
Educational Symposium.
Bleeding Disorders and Thrombosis
Chairs: Nevine Kassim (Egypt),
Osman Bülent Zülfikar (Turkey)
Educational Symposium. New Insights in Haemostasis
Chairs: Ahmet Muzaffer Demir (Turkey),
Gül Öngen (Turkey)
11:15 11:45
Aging Problems in Adult Hemophilia
Jean-François Schved (CHU Hospital, France)
Thrombin, Thrombomodulin and TAFI in the Molecular
Link between Coagulation and Fibrinolysis
Hugo Ten Cate (Maastricht University Medical Center, The
Netherlands)
11:45 12:15
Management of Thrombotic Events in Patients with
Congenital Bleeding Diseases
Muhlis Cem Ar (Istanbul University, Turkey)
New Insights in the Role of Protein C System in
Hemostatic and Non-Hemostatic Functions
John H. Griffin (The Scripps Research Institute, USA)
12:15 12:45
Inhibitor issues in Hemophilia: Bench to Bedside Bagirath Gangadharam (Baxalta Innovations GmbH, Austria)
Acetylation of Proteins in Platelets, a new Signal
Transduction Mechanism
Antonio Moscardó (University Hospital La Fe, Spain)
13:00 - 14:00
Satellite Symposia
Fener Auditorium
Eyüp Auditorium
Satellite Simposium
Chair: Nilgün Sayınalp (Turkey)
INTERNATIONAL UNION ANGIOLOGY
Revolade at Focus: Management of Adult Chronic ITP
Cases.
Mehmet Ali Özcan (Dokuz Eylül University, Turkey)
Satellite Simposium
Development on non-porcine heparins with a focus on sheep
heparins
Chairs: Marco Guerrini (Italy), Ali Al Hakim (USA)
Rationale for the Development of Sheep Heparins Biosimilar to Porcine
Heparins
Jawed Fareed, (Loyola University Chicago, USA)
Feasibility for the Production of the Biosimilar Sheep Heparin for Clinical
Usage
Yiming Yao, (Ronnsi Pharma Co Ltd., JiangSu, China)
D
T
L
Why do we Need to Develop Heparins from Non-porcine Origin?
Shaker Mousa, (The Pharmaceutical Research Institute at Albany, Albany College
of Pharmacy and Health Sciences, Rensselaer, New York, USA)
Invited Commentary / Discussion
Inam Hussain (Consultant, Hemostasis Research Laboratory, Loyola University
Chicago, USA) and Evi Kalodiki (Ealing Hospital, London, England)
10
M
E
14:15 - 15:45
Thrombotic Microangiopathies
Chairs: Kaan Kavakli (Turkey),
Abdulkareem Mohammed Almomen (Saudi Arabia)
Educational Symposium. Current Concepts of VTE
Chairs: Mehmet Hamdi Kurtoglu (Turkey),
Mehmet Hamdi Kurtoglu (Turkey)
14:15 14:45
Atypical Hemolytic Uremic Syndrome: from Molecular
Abnormalities to Clinical Issues
Pier Mannuccio Mannucci (IRCCS, Italy)
New Insights in Genomics of Thrombosis
Frits Rosendaal (University Medical Center, The Netherlands)
14:45 15:15
Thrombotic Microangiopathies:
How ADAMTS13 controls VWF Function
Ergul Berber (Arel University, Turkey)
New Perspectives on Pathophysiology and Management
of the Post-Thrombotic Syndrome
Paolo Prandoni (University of Padova, Italy)
15:15 15:45
New Insights on Physiopathology of DIC
Marcel M. Levi (University of Amsterdam, The Netherlands)
Optimal Long-Term Treatment of Patients with
Unprovoked VTE
Henri Bounameaux (University of Geneva, Switzerland)
15:45 - 16:15
Poster Viewing
16:15 - 17:45
JOINT SYMPOSIUM MLTD/ISTH/CLATH:
Focus on Antithrombotic Treatment
Chairs: Nigel Key (USA), María Teresa Santos (Spain),
María Graciela Pedreira (Uruguay)
Educational Symposium. Antithrombotic Treatment
Chairs: Zeki Öngen (Turkey),
Emre Tekgündüz (Turkey)
16:15 16:45
The forgotten and complex study of fibrinolytic system
María Graciela Pedreira (Hospital de Clínicas Udelar, Uruguay)
An Update on New Anticoagulants
İpek Kıvılcım Ogüzülgen (Gazi University, Turkey)
16:45 17:15
The role of aspirin in the context of dual antiplatelet
treatment in patients with acute myocardial infarction
María Teresa Santos (University Hospital La Fe, Spain)
Reversal of Direct Oral Anticoagulants
Grigoris T Gerotziafas, (Hôpitaux Universitaires Paris, France)
17:15 17:45
Rationale for targeting factors XI and XII with novel
anticoagulant approaches
Nigel Key (UNC Hemophilia & Thrombosis Center, USA)
Dual or triple antithrombotic treatment in coronary artery
disease Raffaele de Caterina (Institute of Cardiology, Italy)
17:45 - 18:15
Poster Viewing
18:00 - 19:00
Debate Session. Thrombolysis in DVT
Chairs: Erdal Aslım (Turkey)
18:15 - 19:45
T
L
M
YES
Athanasios D. Giannoukas
(University Hospital of Larissa, Greece)
NO
Mehmet Hamdi Kurtoglu
(University of Istanbul, Turkey)
EMLTD Councilor’s’
and Board’s Meeting
and
EMLTD General Assembly
E
11
FRIDAY, MAY 6 2016
08:30 - 09:30
Fener Auditorium
Eyüp Auditorium
State of the Art Session. Autoimmune Thrombohemorragic Disorders
Chairs: Hasan Yazıcı (Turkey) Meliha Nalcacı (Turkey)
Educational Symposium
VTE in Surgery
Chairs: Faik Altıntaş (Turkey) Yeşim Erbil (Turkey)
08:30 09:30
Immune Thrombocytopenia in 2016. Reyhan Kucukkaya (Sisli Florence Nightingale Hospital, Turkey)
Systemic Thromboembolism, Organ Dysfunction and
Fatalities Following Trauma and Major Surgery: A new
Protective Strategy. Ola E. Dahl (Innlandet Hospital Trust and Thrombosis Research
Institute, Norway)
09:00 09:30
New Insights in Antiphospholipid Syndrome. Doruk Erkan (Hospital for Special Surgery, USA)
Thromboembolism and prophylaxis in mini-invasive
surgery
Essam Aboelnazar (UQU University, Saudi Arabia)
09:40 - 10:40
Oral Communications
Eyüp Auditorium
Tophane Auditorium
Fener Auditorium
OC-4-TH
OC-5-TH
OC-6-TH
OC-4-TH ANTICOAGULANT DRUGS (Eyüp Auditorium)
Chairs: Jacqueline Conard (France), Vicente Vicente (Spain)
C-0201
CLINICAL PERSPECTIVES ON THE MANAGEMENT OF SEVERE BLEEDING IN PATIENTS TREATED WITH ORAL ANTICOAGULANTS
IN SPAIN. RESULTS OF THE DECOVER STUDY (DELPHI IN ORAL ANTICOAGULATION AND ACTION REVERSAL)
A. Martin, V. Roldán, J. Mateo, J.R. González-Porras, R. Lecumberri, B. Coll-Vinent, P. Marco, C. Suero, S. Soulard, C. Crespo, M.
Camats, M. Pérez, Vicente Garcia
C-0377
IDARUCIZAMAB, A SPECIFIC ANTIDOTE FOR DABIGATRAN, CROSS-REACTS WITH MELAGATRAN AND MAY ALSO INTERACT
WITH OTHER BENZAMIDINE-CONTAINING COMPOUNDS
Jawed Fareed, Amanda Walborn, Debra Hoppensteadt, Jeanine Walenga, Eduardo Ramacciotti, S. Abro, Walter Jeske, Olivia
Bouchard, Ismail Elalmay
C-0327
DIRECT FACTOR XA INHIBITORS FOR PULMONARY EMBOLISM IN PATIENTS INITIALLY ADMITTED TO SUB INTENSIVE CARE UNIT
FOR INTERMEDIATE HIGH RISK INDEX EVENT
Dimitriy Arioli, Monica Casella, Maria Cristina Leone, Giovanni Tortorella, Matteo Azzarone, Massimo Calzolari, Lorenzo Morini,
Francesca Pileri, Elisa Romagnoli, Angela Muoio, Maria Granito, Attilia Maria Pizzini, Annamaria Casali, Emanuele Negri
C-0258
INVESTIGATION OF THE ANTITHROMBOTIC AND ANTIPLATELET EFFECT OF A NEW UREA ANALOG, ON CAROTID ARTERY
THROMBOSIS IN RABBITS
Styliani Papadaki, Iraklis Moschonas, Michail Peroulis, Prokopia Tatsidou, Antonia Sarantou, Constantinos Tellis, George Varvounis,
Alexandros Tselepis
C-0368
MULTILOCUS GENETIC RISK SCORE: A NEW METHODOLOGY FOR THE EVALUATION OF THE RISK FOR IDIOPATHIC VENOUS
THROMBOEMBOLISM
G.T. Gerotziafas, Celine Delassassegne, Virgine Planche, Ismail Elalamy
C-0092
DIFFERENTIAL PLATELET ACTIVATION AFTER P2Y12 INHIBITION
Leunissen Tesse Charlotte, Wisman Peter Paul, Van Holten Thijs, De Groot Philip, Remijn Jasper, Frans Moll, De Borst Gert Jan,
Teraa Martin, Verhaar Marianne, Urbanus Rolf, Roest Mark
D
T
L
OC-5-TH ANTITHROMBOTIC DRUGS / CEREBRAL THROMBOSIS (Tophane Auditorium)
Chairs: María Graciela Pedreira (Uruguay), Joan Montaner Villalonga, (Spain)
12
C-0365
BRANDED AND COPIES OF THE LOW MOLECULAR WEIGHT ENOXAPARIN; ARE THEY SAME?
Grigoris T Gerotziafas, Aurèlie Rousseau, Elisabeth Mbemba, Amir Khartechi, Patrick Van Dreden, Janine Walenga, Annette Larsen,
Jawed Fareed, Ismail Elalamy
C-0176
A MULTINATIONAL, MULTICENTRE, RANDOMIZED, OPEN-LABEL, PARALLEL GROUP STUDY ON THE EFFICACY AND SAFETY OF
ONCE DAILY BEMIPARIN COMPARED TO TWICE DAILY ENOXAPARIN IN THE TREATMENT OF ACUTE DEEP VEIN THROMBOSIS
Sebastian M. Schellong, Javier Martinez-Gonzalez, Igor Alexandrovich Suchkov, Michela Falciani, Maria Theresia Kaltwasser
C-0177
ASSESSMENT OF BLEEDING RISK IN ELDERLY AND PATIENTS WITH RENAL IMPAIRMENT UNDER BEMIPARIN PROPHYLACTIC
DOSES FOR MORE THAN 3 WEEKS
Javier Martinez-Gonzalez, Ignacio Ayani
C-0204
SURFACE EXPRESSION OF TYRO3, AXL AND MER RECEPTORS ON PLATELETS IN PATIENTS WITH TYPE 2 DIABETES
Fikriye Uras, Husniye Dagdeviren, Derya Ozsavci, Ozlem Bingol Ozakpinar, Gulderen Yanikkaya Demirel, Hasan Aydin, Sami Karti
M
E
C-0224
TOLERABILITY AND EFFICACY OF ELTROMBOPAG IN CHRONIC IMMUNE-MEDIATED THROMBOCYTOPENIA: META-ANALYSIS OF
RANDOMIZED CONTROLLED TRIALS
Ahmed Elgebaly, Gehad El Ashal, Ahmed Menshawy, Mohamed Elfil
C-0358
PLATELET HEAT SHOCK PROTEIN 70 (HSP70) IS A REGULATOR OF PLATELET INTEGRIN ACTIVATION, GRANULE SECRETION
AND AGGREGATION
Rachel Rigg, Laura D. Healy, Marie S. Nowak, Jérémy Mallet, Marisa L. D. Thierheimer, Jiaqing Pang, Owen J. T. Mccarty, Joseph E.
Aslan
OC-6-TH PREGNANCY AND THROMBOSIS / DVT AND PE (Fener Auditorium)
Chairs: Nil Güler, Turkey; Fikriye Uras, Turkey
10:40 - 11:15
C-0336
PREGNANCY IN HIGH RISK ANTITHROMBIN DEFICIENCY: PREVENTION OF VENOUS THROMBOEMBOLISM WITH THE LMW
HEPARIN PROPHYLAXIS REGIMENS USED IN NORDIC COUNTRIES
Ingunn Dybedal, Anne Mette Hvas, Rosa Chiarete, Anne Flem Jacobsen, Per Morten Sandset, Harald Weedon-Fekjar, Katarina
Bremme, Ulrich Abildgaard
C-0060
THE IMPACT OF RESIDUAL OBSTRUCTION ON THE LONG-TERM OUTCOME OF PATIENTS WITH PULMONARY EMBOLISM
Raffaele Pesavento, Lucia Filippi, Antonio Palla, Anna Chiara Frigo, Adriana Visonà, Carlo Bova, Stefano Cuppini, Ferdinando Porro,
Sabina Villalta, Maurizio Ciammaichella, Eugenio Bucherini, Giovanni Nante, Stefano Battistelli, Giampietro Beltramello, Domenico
Prisco, Paolo Prandoni
C-0084
CLINICAL COURSE OF PATIENTS WITH VENOUS THROMBOEMBOLISM (VTE) AND INFERIOR VENA CAVA FILTER (IVCF): COHORT
STUDY
Maria Lourdes Posadas-Martinez, María Florencia Grande-Ratti, Paula Gutiérrez, Fernán González Bernaldo De Quirós, Diego
Hernán Giunta, Fernando Javier Vázquez
C-0143
VENOUS THROMBOEMBOLISM IN WOMEN USING HORMONAL CONTRACEPTION. FINDINGS FROM A SINGLE CENTER
Alba Sara Vilches Moreno, Alejandra Latorre González, Miriam Vilches Moreno, Begoña Fernández Jiménez, Jacobina Cachá
Acosta, María Jesús Gómez Vázquez
C-0261
USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY
Demet Cekdemir, Fusun Ozdemirkiran, Serkan Guvenc, Ali Eser, Vildan Ozkocaman, Handan Haydaroglu Sahin, Esra Ermis Turak,
Erdal Kara, Melda Comert, Sevil Sadri, Muzeyyen Aslaner, Bahar Uncu Ulu, Abdullah Karakus, Derya Selim Bapur, Demet Aydin, Inci
Alacacioglu, Atakan Tekinalp, Sinem Namdaroglu, Funda Ceran, Pinar Tarkun, Demet Kiper, Mustafa Cetiner, Mustafa Yenerel, Elif
Gulsum Umit, Guven Yilmaz, Hatice Terzi, Erden Atilla, Umit Yavuz Malkan, Kadir Acar, Erman Ozturk, Anil Tombak, Cenk Sunu, Ozan
Salim, Nevin Alayvaz, Ozkan Sayan, Ulku Ozan, Mesut Ayer, Zafer Gokgoz, Neslihan Andic, Ebru Kizilkilic, Figen Noyan, Mehmet Ozen,
Funda Pepedil Tanrikulu, Guchan Alanoglu, Hasan Atilla Ozkan, Vahap Aslan, Guven Cetin, Alev Akyol Erikci, Burak Deveci, Fadime
Ersoy Dursun, Hasan Dermenci, Olga Meltem Akay Yanar, Duzgun Ozatli, Levent Undar, Eyup Naci Tiftik, Ayhan Gulsan Turkoz Sucak,
Ibrahim Haznedaroglu, Muhit Ozcan, Mehmet Sencan, Ahmet Muzaffer Demir, Murat Tombuloglu, Gulsum Ozet, Oktay Bilgir, Burhan
Turgut, Mehmet Ali Ozcan, Kadriye Bahriye Payzin, Mehmet Sonmez, Orhan Ayyildiz, Mehmet Sinan Dal, Sehmus Ertop, Teoman
Soysal, Emin Kaya, Ramazan Eser, Ali Unal, Mustafa Pehlivan, Tulin Tuglular Firatli, Guray Saydam, Reyhan Diz Kucukkaya
C-0229
DESIGN AND APPLICATION OF A TWENTY-THREE-GENE PANEL BY NEXT-GENERATION SEQUENCING FOR INHERITED
COAGULATION BLEEDING DISORDERS.
Jose Maria Bastida, Monica Del Rey, Kamila Janusz, Ana Hortal, Rocio Benito, Maria Eugenia Sarasquete, Maria Luisa Lozano, Elena
Fontecha, Rosa Fisac, J. Javier Garcia Frade, Carlos Aguilar, M. Paz Martinez, Emilia Pardal, Carmen Aguilera, Jose Manuel Martin
Antoran, Beatriz Perez, Nuria Bermejo, Rafael Ramos, Luz Angela Silvestre, Maria Jose Cebeiro, M. Rosa Cardesa, Jesus Maria
Hernandez Sanchez, Miriam Lopez Parra, Julio Davila, Jesus Maria Hernandez Rivas, Jose Ramon Gonzalez Porras
E
Anticoagulation in Atrial Fibrilation
Chairs: Kürsat Bozkurt (Turkey),
11:15 - 12:15
T
L
M
11:15 11:45
CHA2DS2-VASc Score=1: No Treatment, Aspirin or Oral
Anticoagulation?
Peter Brønnum Nielsen (Aalborg University, Denmark)
11:45 12:15
Do Vitamin K Antagonists (VKAs) still have a Role in the
Management of AF?
Vanessa Roldán (Hospital Universitario Morales Meseguer, Spain)
13
13:00 - 14:00
Satellite Symposia
Fener Auditorium
Eyüp Auditorium
Tophane Auditorium
Satellite Simposium
Satellite Simposium
Personalized Prophylaxis in
Hemophilia
Chair: Aysegül Ünüvar, Turkey
The importance of personalizing
treatment in Hemophilia
Muhlis Cem Ar, (Turkey)
New inside in Thrombotic
Complications of PNH
Chair: Mahmut Töbü, (Turkey)
INTERNATIONAL UNION ANGIOLOGY
Satellite Simposium
Recombinant Coagulation Factors and their
Biosimilar Counterparts. A Case of Factor VIIa in
The Management of hemophilia with Inhibitors
Chairs: Ahmet Muzaffer Demir (Turkey), Lorenzo Montrasio
(Italy)
The Clinical and diagnostic
Appoach to PNH
Mustafa Nuri Yenerel (Istanbul
University, Turkey)
Biosimilar Recombinant Proteins and the Current
Regulatory Guidelines for Clinical Use
Massimo Iacobelli (Consultant on Pharmaceutical Strategic
Planning and Development, Loyola University Chicago,
Chicago, USA)
The role of pharmacokinetic dosing in
personalized prophylaxis
Can Balkan, (Turkey)
Biosimilar Factor VIIa is Comparable to Branded
Novoseven. Clinical Validation
Jawed Fareed (Loyola University Chicago, Chicago, USA)
Review of the Clinical Trials on a Biosimilar
Recombinant Factor VIIa in Various Clinical Studies
Mohammad Faranoush (Hematologist and Oncologist, Iran
University of Medical Sciences, Tehran, Iran)
14:15 - 15:15
Thrombotic and Bleeding Disorders in Women
Chairs: Aysegül Ünüvar(Turkey), Gülnihal Özdemir (Turkey)
Postpartum Hemorrhage in Carriers of Hemophilia and
Women with VWD
Danijela Mikovic (Blood Transfusion Institute of Serbia)
14:15 14:45
Biosimilar and Generic Drugs for the Management of
Bleeding and Thrombosis
Jawed Fareed (Loyola University, USA)
14:45 15:15
Regulatory Pathways for Biosimilar Coagulation Proteins
or Regulatory pathways for Biologics Lorenzo Montrasio (AIFA, Italy)
15:15 - 15:45
Poster Viewing
15:45 - 17:15
Cancer Associated Thrombosis
Chairs: Turgut Ulutin (Turkey),
Shaker Mousa (USA)
Antiplatelet Therapy
Chair: Mehmet Ağırbaşlı (Turkey),
Antonio Hatzizacharias (Greece)
15:45 16:15
Microvesicules as Mediators of Tumor Progression
Johannes Thaler (Medical University of Vienna, Austria)
Inhibition of Protease-Activated Receptors: New Insights
in Antiplatelet Therapy
David Varon (Hadassah-Hebrew University Medical Center, Israel)
16:15 16:45
The Role of Blood Cells in Cancer Associated Thrombosis
Ingrid Pabinger (Medical University of Vienna, Austria)
P2Y12 Receptor Blockers in Cardiovascular Disease: An
Update
Lina Badimon (CSIC-ICCC, Spain)
16:45 17:15
Prophylaxis and treatment of venous thromboembolism in
patients with cancer
Shaker Mousa (Albany College of Pharmacy and Health
Sciences, Rensselaer, New York, USA)
17:15 - 18:15
14
State of the Art Session
Biosimilars and Generics Issue on Thrombosis
Chairs: Grigorios Gerotziafas (France)
D
T
L
Cerebrovascular/Peripheral Arterial Diseases
Chairs: Evgeny Roitman (Russia), Birsen Ince (Turkey)
The risk prediction and treatment of VTE
Chairs: Cafer Adiguzel (Turkey), Mehmet Nejat Akar (Turkey)
M
E
17:15 17:45
The Pathophysiology of Ischemic Stroke: Focus on
Biomarkers
Joan Montaner Villalonga (VHIR, Spain)
Risk prediction for VTE recurrency
Yesim Dargaud (Hôpital Cardiologique Louis Pradel, France)
17:45 18:15
Clinical and Surgical Management of Patients with
Peripheral Vascular Diseases
Christos D. Liapis (Athens University Medical School, Greece)
The treatment of Pulmonary embolism: Russian
Perspective
Igor Bokarev (I. M. Sechenov First Moscow State Medical
University, Russia)
SATURDAY, MAY 7 2016
08:30 - 09:30
MEYER-MICHEL SAMAMA HALL
ORHAN N. ULUTIN HALL
Fener Auditorium
Eyüp Auditorium
Young Investigator Session
Chairs: Zafer Baslar (Turkey),
Tulin Tiraje Celkan (Turkey)
State of the Art Session.
Thrombosis in Children
Chairs: Hale Ören (Turkey)
08:30 09:00
Mouse Models of Venous Thrombosis. Teresa Padró (CSIC-ICCC, IIB Sant Pau, Spain)
Thrombolytic Treatment in Pediatric Stroke. Uluc Yis (Dokuz Eylul University, Turkey)
09:00 09:30
Number needed to treat (NNT) and number needed to
harm (NNH): What do they tell for clinicians?
Oktay Ozdemir (Turkey)
Hemostatic Alterations in Sickle Cell Syndrome. Sule Unal (Hacettepe University, Turkey)
09:40 - 10:40
Oral Communications
Eyüp Auditorium
Fener Auditorium
OC-7-TH
OC-9-TH
OC-7-TH VTE IN CANCER / SURGERY (Eyüp Auditorium)
Chairs: Shaker Mousa (USA), Sermin Tetik, Turkey
C-0059
THE VALUE OF COMPUTED TOMOGRAPHY FOR THE DETECTION OF OCCULT CANCER IN PATIENTS WITH UNPROVOKED
VENOUS THROMBOEMBOLISM (D’ACQUAPENDENTE STUDY)
Andrea Piccioli, Enrico Bernardi, Fabio Dalla Valle, Adriana Visonà, Pietro F Tropeano, Carlo Bova, Eugenio Bucherini, Paolo Prandoni
C-0113
VENOUS THROMBOEMBOLISM PREVENTION IN ONCOLOGY PATIENTS WITH RADIATION THERAPY (VERT STUDY)
Mikhail Cherkashin, Natalia Berezina, Nicolay Vorobyov, Alexey Mikhailov, Alexey Serov
C-0371
FIBRINOLYTIC DYSREGULATION IN ARTHROPLASTY PATIENTS MAY CONTRIBUTE TO POSTOPERATIVE HEMOSTATIC
COMPLICATIONS
Nil Guler, Christopher Wanderling, Drew Burleson, Debra Hoppensteadt, Harold Rees, Jawed Fareed, William Hopkinson
C-0299
CANCER PROCOAGULANTS PROMOTE TUMOR GROWTH AND ANGIOGENESIS IN BREAST CANCER PROGRESSION; AN IN VIVO
BIOMARKER STUDY
Sermin Tetik, Samet Ergun, Sadik Sahin, Nusret Erdogan
C-0132
LOW PREVALENCE OF SYMPTOMATIC VENOUS THROMBOEMBOLISM FOLLOWING RENAL TRANSPLANTATION
Ana Virginia Figueroa Córdoba, Danilo Musso, Gabriela Robaina, Gustavo D. Martini, Ricardo Arturo Albertini, Carlos Chiurchiu, Aldo
Hugo Tabares
C-0125
INCREASED PLATELET ACTIVATION AND P-SELECTIN IN OBSTRUCTIVE SLEEP APNEA SYNDROME
Cigdem Bayram Gurel, Engin Korkmaz, Suzan Adn Çnar, Gülsel Ayaz, Gönül Kangür, Günnur Deniz, Turgut Ulutin, Bülent Tutluolu
T
L
M
E
C-TH-9 ANTITHROMBOTIC DRUGS / ARTERIAL THROMBOSIS AND ATHEROSCLEROSIS / ATRIAL FIBRILLATION (Fener Auditorium)
Chairs: Ayşen Yarat (Turkey), Antonio Moscardó (Spain)
10:40 - 11:15
C-0263
NEUTROPHIL EXTRACELULAR TRAPS IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME ARE
ASSOCIATED WITH MARKERS OF PLATELET ACTIVATION
Ana Latorre, María Ferré, Maria Paz Fuset, Elena Sánchez, Isabel Madrid, Juana Vallés, Antonio Salvador, Maria Teresa Santos,
Antonio Moscardó
C-0189
CORONARY THROMBUS CHARACTERIZATION: NATIVE CORONARY THROMBOSIS AND IN-STENT THROMBOSIS
Judit Cubedo, Rosa Suades, Javier Goicolea, Teresa Padró, Ana Blasco, Lina Badimon
C-0141
THROMBIN-INDUCED PLATELET ACTIVATION AND MICROVESICLE RELEASE: PROTEOMIC SIGNATURE OF PLATELET-DERIVED
MICROVESICLES
Rosa Suades, Teresa Padro, Estefania Segales, Lina Badimon
C-0037
EXOPOLYPHOSPHATASE BASED STRATEGIES FOR INTERFERENCE WITH PROCOAGULANT POLYPHOSPHATE ACTIVITIES
Linda Labberton, Thomas Renné
15
11:15 - 12:45
Presidential Farewell Symposium.
Crosslink between Inflamation and Thrombosis
Chairs: Lina Badimon (Spain),
Ahmet Muzaffer Demir (Turkey),
11:15 11:45
NETosis and Innate Immunity: Focus on Thrombosis
Gemma Vilahur (CSIC-ICCC, IIBSantPau, Spain)
11:45 12:15
Polyphosphates and Contact Factors: Links among
Coagulation, Platelets and Inflammation
Thomas Renné (Karolinska Institute and Universitz Hospital)
12:15 12:45
Circulating Non-Coding RNAs as Active Contributors in
Thrombosis
Teresa Padró (CSIC-ICCC, IIB Sant Pau, Spain)
12:45 – 13:00
Closing Session
D
T
L
16
M
E
POSTERS
Animal, cellular and
molecular research in
thrombosis
P-0052 DIFFERENTIATION OF ANTAGONISTS OF PROTEINASE ACTIVATED RECEPTOR 1 AND 4 IN NONHUMAN PRIMATE MODELS OF HEMOSTASIS AND ANTI-THROMBOSIS
A Wickham, M Michener, L Handt, A Basso, S Fried, L Chu, M Maderia, K Owens, J Imbriglio, K Wang, J Metzger, Tian-Quan Cai
Animal, cellular and molecular research in thrombosis
P-0139 INFLUENCE OF ANTICOAGULANT THERAPY TYPE ON THE QUALITY OF
LIFE IN PATIENTS WITH DEEP VENOUS THROMBOSIS
Igor Suchkov, Roman Kalinin, Nina Mzhavanadze, Andrey Agapov
P-0237 DOES TOPICAL APPLICATION OF TRANEXAMIC ACID DURING CARDIAC ELECTRONIC DEVICE IMPLANTATION AFFECT COAGULATION
PROFILE?
Osman Beton
P-0239 THROMBOPROPHYLAXIS WITH RIVAROXABAN AFTER TOTAL HIP AND
KNEE ARTHROPLASTY - OUR THREE YEARS EXPERIENCE
Elena Ambarkova-Vilarova, George Zafirovski, Saso Mladenovski,
Konstantin Mitev
P-0101 ANTITHROMBOTIC AGENTS, RIVAROXABAN AND CILOSAZOL, PREVENT LUNG AND RENAL INJURY FOLLOWING ABDOMINAL AORTA
ISCHEMIA / REPERFUSION IN A RAT MODEL
Orhan Findik, Ahmet Tugrul Eruyar, Atike Tekeli Kunt, Seda Gulec Yilmaz, Selim Isbir, Hakan Parlar, Ozgur Baris, Canan Balci, Emre Murat
Altinkilic, Selda Turkmen, Huseyin Kilili, Turgay Isbir
P-0241 VITAMIN K DEFICIENCY DUE TO STRICT LOW VITAMIN K DIET IN
PATIENTS WHO ARE ON LONG-TERM WARFARIN ANTICOAGULATION
Abdulkareem Almomen Mohammed, Maher Khosayfan, Sayed Husseini, Sarah Arbab
P-0103 AN ANTIPLATELET AGENT, CILOSTAZOL, ATTENUTATES MYOCARDIAL
DAMAGE INDUCED BY ABDOMINAL AORTA ISCHEMIA / REPERFUSION IN A RAT MODEL
Atike Tekeli Kunt, Orhan Findik, Seda Gulec Yilmaz, Ahmet Tugrul Eruyar, Hakan Parlar, Ozgur Baris, Canan Balci, Emre Murat Altinkilic,
Selda Turkmen, Altay Burak Dalan, Hüseyin Ayhan, Selim Isbir, Turgay
Isbir
P-0340 EFFICIENCY OF DIRECT ORAL ANTICOAGULANTS ON ANTIPHOSPHOLIPID ANTIBODY SYNDROME: A CASE REPORT
Muhammet Maden, Elif Gulsum Umit, Sule Erdogan, Ahmet Muzaffer
Demir
P-0350 ASSESSEMENT OF QUALITY OF ANTICOAGULATION WITH VKA IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
Helena Cruz Gomes, Fátima Correia, Luciana Gonçalves, Carla Monteiro, Manuela Carvalho, Beatriz Delgado, Carmo Koch, Graça Oliveira
P-0285 ENDOMETRIAL MRNA EXPRESSIONS OF CYTOKINES IN WOMEN WITH
IN VITRO FERTILIZATION FAILURE
Sadik Sahin, Dilsad Herkiloglu, Enver Ciraci, Sevgin Degirmencioglu,
Tayfun Unal, Fikriye Uras, Sermin Tetik
P-0361 THE EFFECT OF MYRTUS COMMUNIS EXTRACT ON RENAL INJURY IN
RATS WITH BILE DUCT LIGATION
Leyla Alev, Burcin Alev-Tuzuner, Sehkar Oktay, Goksel Sener, Aysen
Yarat
Anticoagulant drugs
P-0087 META-ANALYSIS OF THE EFFECTIVENESS AND SAFETY OF NEW ORAL
ANTICOAGULANTS IN THE TREATMENT OF VENOUS THROMBOEMBOLISM
Olga Shatalova, Vladislav Gorbatenko, Olga Smuseva, Alexander
Maslakov, Andrei Shatalov
P-0100 THE TREATMENT OF VENOUS THROMBOEMBOLISM
Aliya Toleuova, Dana Tayzhanova, Zhazira Beysenbekova, Zauresh
Tauesheva, Zukhra Guseinova, Rakhima Toyynbekova, Olga Visternichan, Ayman Zhusupova, Malina Mandybayeva, Zamira Kenzhetayeva
P-0114 APPLICATION OF BASIC AND SPECIAL COAGULATION TESTS FOR
MEASURING RIVAROXABAN ACTIVITY
Aránzazu García Raso, Rosa Vidal, Aránzazu García Raso, Susana
Asenjo, Ana Huertas, Laura Solán, Teresa Arquero, Belén Iñigo, Pilar
Llamas
P-0372 PRE-EXISTENCE OF PROTHROMBOTIC STATE IN PATIENTS WITH
ATRIAL FIBRILLATION DESPITE THERAPY WITH NEW AND TRADITIONAL ANTI-COAGULANT DRUGS
Jawed Fareed, Jeff Lifes, Christopher Wanderling, Jordan Liles, Debra Hoppensteadt, Daneyal Syed, Mushabbar Syed
M
E
P-0375 OVINE AND PORCINE HEPARINS EXHIBIT BIOSIMILARITIES IN CONTRAST TO BOVINE COUNTERPARTS
Yiming Yao, Olivia Bouchard, Debra Hoppensteadt, Paula Maia, Alice
Silva De Castro, Emmanuel Kumar, Nil Guler, Walter Jeske, Daniel
Kahn, Jeanine Walenga, Erwin Coyne, Jawed Fareed
P-0175 PROTEOLYSIS AND ISOPEPTIDOLYSIS DURING THROMBOLYSIS
Sergey Kalabushev, Alexey Kurdyumov, Valentin Manuvera, Nadezhda
Antipova, Dmitry Akhaev, Vasiliy Lazarev, Izolda Baskova
P-0238 MAJOR BLEEDING COMPLICATIONS DURING CARDIAC ELECTRONIC
DEVICE IMPLANTATION IN PATIENTS RECEIVING ANTITHROMBOTIC
THERAPY: DO LOCAL TRANEXAMIC ACID HAVE ANY PREVENTIVE
ROLE?
Osman Beton
P-0254 EXPLORING THE SPECIFICITY AND OPTIMAL CONDITIONS FOR EXPRESSING THE MAXIMUM ACTIVITY OF THE NOVEL ANTIPLATELET
AGENT VORAPAXAR, IN VITRO
Iraklis Moschonas, Styliani Papadaki, Alexandros Tselepis
P-0272 IDENTIFICATION OF NEW BIOMARKERS FOR HIGH ON-TREATMENT
PLATELET REACTIVITY TO ASPIRIN AND CLOPIDOGREL
Maria Tsoumani, Ioannis Ntalas, John Goudevenos, Alexandros Tselepis
P-0316 EVALUATION OF RESISTANCE TO STANDARD ANTIPLATELET THERAPY IN PATIENTS UNDERGOING UNSTABLE ANGINA
Ludmila Gelis, Alena Miadzvedzeva, Irina Lazarava, Inga Markava, Irina Russkikh, Marina Kaliadka, Tatsiana Rusak, Natallya Shibeka
P-0345 EVALUATION OF TIME IN THERAPEUTIC RANGE IN ANTICOAGULATED
PATIENTS WITH VENOUS THROMBOEMBOLISM: A SINGLE-CENTER,
RETROSPECTIVE, OBSERVATIONAL STUDY
Tazi Mezalek Zoubida, Iraqi Fatima-Zohra, Mounfaloti Wafaa, Bourkia
Meriem, Ammouri Wafaa, Maamar Mouna, Harmouche Hicham
Arterial thrombosis and
atherosclerosis
P-0091 SERUM URIC ACID AND ALBUMIN LEVELS ARE ASSOCIATED WITH
DEEP VENOUS THROMBOSIS
Atike Tekeli Kunt, Orhan Findik, Selim Isbir, Seda Gulec Yilmaz, Gokcen Atilboz Alagoz, Emre Murat Altinkilic, Hakan Parlar, Turgay Isbir
P-0096 CLINICAL CHARACTERISTICS AND ETIOLOGIES OF ARTERIAL THROMBOSIS: A SERIES OF 45 PATIENTS
Thouraya Ben Salem, Molka Togourti, Imed Ben Ghorbel, Monia
Khanfir, Mounir Lamloum, Mohamed Habib Houman
P-0099 LIPID METABOLISM AND COAGULATION FACTORS IN PATIENTS WITH
CORONARY ARTERY DISEASE AFTER STENTING
Aliya Toleuova, Zukhra Guseinova, Zhazira Beysenbekova, Zauresh
Tauesheva, Rakhima Toyynbekova, Malina Mandybayeva, Olga Visternichan, Ayman Zhusupova, Zhanar Turhanova, Zamira Kenzhetayeva
P-0133 RETROSPECTIVE EVALUATION OF PATIENTS WITH ACUTE MESENTERIC ISCHEMIA
Süleyman Bademler, Mehmet Ilhan, Ibrahim Fethi Azamat, Abdulmuttalip Baysal, Ali Fuat Kaan Gök, Recep Güloglu, Mehmet Kurtoglu
P-0273 ARE AGE AND JAK2V617F MUTATION RELATED TO TROMBOSIS IN
CHRONIC MYELOPROLIFERATIVE DISEASES?
Pinar Ataca, Erden Atilla, Sinem Civriz Bozdag, Selami Kocak Toprak,
Meltem Kurt Yuksel, Pervin Topcuoglu, Hamdi Akan, Onder Arslan,
Muhit Ozcan, Meral Beksac, Gunhan Gurman, Osman Ilhan
P-0280 SUDDEN ONSET VISION LOSS AS AN INITIAL MANIFESTATION OF
ELEVATED SERUM LIPOPROTEIN(A) LEVELS: REPORT OF TWO
CASES
Huseyin Tokgoz, Umran Caliskan, Mehmet Okka, Hurkan Kerimoglu,
Gulfidan Bitirgen
Atrial fibrillation
P-0041 STUDY OF SAFETY AND EFFECTIVENESS OF DABIGATRAN TO PREVENT THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
Juan Jose Cerezo Manchado, Pastora Iniesta, Antonia Melero
P-0353 THE PREVENTION OF TROMBOEMBOLIC COMPLICATIONS IN
NON-VALVULAR ATRIAL FIBRILLATION G.T. Igimbayeva, Seyed Farzad Jalali, S.A. Salehov, V.Ju. Kolybyuk
Coagulation and Tissue
factor
P-0312 EVALUATION OF PATIENTS WITH HEMOPHILIA; ULUDAG UNIVERSITY
EXPERIENCE
Hilmi Erdem Gözden, Fahir Özkalemka, Vildan Özkocaman, Tugcan
Alp, Zafer Serenli Yeen, Rdvan Ali
P-0360 EFFECT OF EXERCISES AND CALORIC RESTRICTION ON SOME BIOCHEMICAL PARAMETERS OF BRAIN TISSUES IN METABOLIC SYNDROME MODEL
Nevin Genc-Kahraman, Burcin Alev, Hazal Ipekci, Unsal Veli Ustundag,
Tugba Tunali-Akbay, Ebru Emekli-Alturfan, Goksel Sener, Aysen Yarat
Coronary, cerebrovascular
and peripheral vascular
disease
P-0053 VERTEBROBASILAR DOLICHOECTASIA AND STROKE RISK FACTORS
Birsen Ince, Bengi Gul Alpaslan
P-0062 HYPERTRIGLYCERIDEMIA AND ISCHEMIC STROKE
Birsen Ince, Zehra Hasiloglu
P-0064 ANTIPHOSPHOLIPID ANTIBODIES AND STROKE RECURRENCE IN
WOMEN
Ayse Deniz Elmali, Birsen Ince
P-0076 IS IT TAKAYASU’S ARTERITIS? – EVIDENCE FROM ANGIOGRAPHIC
PATTERNS IN SRI LANKA
Dewa Pakshage Chula Kanishka Ananda Lal
D
T
L
P-0288 SUBOCCLUSIO ARTERIAE SUBCLAVIAE IN A 50-YEAR-OLD WOMEN:
CASE REPORT
Akif Mlaco, Sanela Vesnic, Demir Bejtovic, Vesna Djurovic-Sarajlic,
Abel Baltic
P-0326 RISK FACTORS, TREATMENT AND PROGNOSIS OF THROMBOSIS IN
CHILDREN, A SINGLE CENTER EXPERIENCE
Esra Pekpak, Esra Pekpak, Elif Ince, Talia Ileri, Mehmet Ertem, Hasan
Cakmakli, Basak Aksoy, Zumrut Uysal
M
E
P-0349 THE ROLE OF BIOCHEMICAL MARKERS IN ATHEROTHROMBOSIS
WITH PLATELET ACTIVATION-RELATED; AN IN VIVO PROSPECTIVE
STUDY
Sermin Tetik, Tayfun Unal, Koray Ak, Sinan Arsan
P-0122 CLINICO-LABORATORY PREDICTORS OF CORONARY RESTENOSIS IN
MAN OF KAZAKH NATIONALITY
Olga Visternichan, Dana Taizhanova, Elena Zholdybayeva, Pavel Tarlykov
P-0158 VENOUS THROMBOSIS IN UNUSUAL SITES: THROMBOPHILIA MARKERS
Aya Chakroun Slama, Hela Baccouche, Sonia Mahjoub, Neila Benromdhane
P-0161 CEREBRAL AMYLOID ANGIOPATHY AND MRI-VISIBLE PERIVASCULAR
SPACES
Birsen Ince, Gulcin Benbir Senel
P-0271 A COMPARISON OF CILOSTAZOL AND PENTOXIFYLLINE FOR TREATING INTERMITTENT CLAUDICATION.: SYSTEMATIC REVIEW & META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Gehad El Ashal, Ahmed Elgebaly
P-0192 ATYPICAL LOCATIONS OF VENOUS THROMBOSIS: A STUDY OF 47
CASES
Hamrouni Sarra, Boussetta Najeh, Faida Lajili, Yosra Ben Ariba, Jannet Laabidi, Bassem Louzir, Nadia Ben Abdelhafidh, Salah Othmani
P-0347 INTERMITTENT LDL LOWERING THERAPY: RESET THE VASCULAR AGING CLOCK
Amina Bico, Azra Kurcehajic, Alden Begic, Mirza Dilic
P-0197 THE SPLANCHNIC VENOUS THROMBOSIS: ABOUT 20 CASES
Hamrouni Sarra, Najeh Boussetta, Sameh Sayhi, Rim Abid, Jannet
Laabidi, Faida Laajili, Bassem Louzir, Nadia Ben Abdelhafidh, Salah
Othmani
P-0348 WHAT IS DE FACTO SUBCLINICAL ATHEROSCLEROSIS: BIOMARKER,
CONDITION OR DISEASE?
Azra Kurcehajic, Amina Bico, Alden Begic, Mirza Dilic
P-0355 SERUM VITAMIN B12 AND FOLIC ACID LEVELS IN ACUTE CEREBRAL
ATHEROTHROMBOTIC INFARCTION
Amrane Mounira, Mouhamed Chahine Chekour, Nada Boutrid, Hakim
Rahmoun, Boussouf Khaira, Bakhouche Houcher, Ramdane Nasri,
Abderrezak Touabti, Moufek Charefeddine
Deep vein thrombosis and
PE
P-0045FORGOTTEN ENEMY. HEMORHEOLOGIC DISTURBANCES CAN LEAD
TO THROMBOSIS IN SOME MYELOPROLIFERATIVE NEOPLASMS
Eugene Roitman, Irina Kolesnikova, Igor Davydkin, Natalia Kozlova,
Eugene Roitman
P-0262 ELASTOGRAPHY OF VENOUS THROMBI AT THE ER: IS IT A HELPFUL
TOOL?
Triantafyllou Evaggelia, Papaevangelou Aggeliki, Pithara Christala,
Mihalopoulou Anna
P-0074 SYMPTOM OF „IRONED OUT GLUTEAL SULCUS” – A RELIABLE DIFFERENTIAL DIAGNOSTIC “TOOL” FOR THE DIAGNOSIS AND CLINICAL
MONITORING OF THE DEEP VENOUS THROMBOSIS (DVT) OF ILIAC
VEINS
Iovtcho Topalov, Georgi Marinov
P-0085 PLATELET VOLUME AS A PROGNOSTIC FACTOR OF PULMONARY
THROMBOEMBOLISM
Maria Lourdes Posadas-Martinez, Juan Manuel Díaz, Bruno Boietti,
Fernán González Bernaldo De Quirós, Veronica Peucheot, Fernando J
Vazquez, Liliana Paloma Rojas, Diego Giunta
P-0126 THE CORRELATION BETWEEN PLASMA D-DIMER AND PLASMA AND
URINE PROTHROMBIN FRAGMENT 1 + 2 IN NON-COMORBID PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS.
Fredrik Wexels, Ingebjørg Seljeflot, Are H. Pripp, Ola E. Dahl
P-0155 ASSOCIATION OF TISSUE FACTOR PATHWAY INHIBITOR GENE POLYMORPHISMS 399C/T AND 33T/C WITH DEEP VEIN THROMBOSIS
Kamal Kishor, Ravi Kumar, Amit Sharma, Hare Ram Pandey, Ravi Ranjan, Pravas Mishra, Renu Saxena
P-0198 TOPOGRAPHIC PROFILES OF UNUSUAL LOCATION VENOUS THROMBOSIS DURING VASCULITIS
Hamrouni Sarra, Najeh Boussette, Jannet Laabidi, Sameh Sayhi, Nadia Ben Abdelhafidh, Faida Laajili, Salah Othmani
P-0206 VENOUS THROMBOEMBOLISM AMONG THE POPULATION OF INTERNAL SECURITY FORCES AGENTS IN TUNISIA
Emna Gharbi, Syrine Bellakhal, Maroua Mrouki, Akil Mestiri, Mohamed Hedi Douggui
P-0232 INFLUENCE OF DECREASED FIBRINOLYTIC ACTIVITY ON VENOUS
THROMBOSIS RISK
Biljana Vuckovic, Gorana Mitic, Valentina Djordjevic
P-0268 POST-TRAUMATIC PORTAL VEIN THROMBOSIS: A RARE INCIDENT
Angeliki Papaevangelou, Evaggelia Triantafyllou, Ekaterini Natsiopoulou, Efstathia Kapnisi, Fotini Statera, Nikolaos Stefanoglou
P-0270 VENOUS INJURY: THE ROLE OF MULTI DETECTOR COMPUTED TOMOGRAPHY (MDCT)
Angeliki Papaevangelou, Evaggelia Triantafyllou, Ekaterini Natsiopoulou, Panagiota Margari, Maria Vidali, Panagiotis Limiatis, Nikolaos
Stefanoglou
P-0283 MESENTERIC VENOUS THROMBOSIS IN FUENLABRADA UNIVERSITY
HOSPITAL. 28 CASES SERIES ANALYSIS
Rafael Cristóbal Bilbao, Barbara Nieto-Sandoval, Cristina Lucía De
Ancos-Aracil, Justo Ruíz-Ruíz, Antonio Zapatero-Gaviria
P-0287 UNUSUAL LOCALIZATIONS OF DEEP VENOUS THROMBOSIS ABOUT
21 CASES.
Emna Gharbi, Syrine Bellakhal, Imen Abdelaali, Taieb Jomni, Mohamed Hedi Douggui
M
E
P-0289 PARKINSON’S DISEASE, HYPERHOMOCYSTEINEMIA AND THROMBOSIS: THE DANGEROUS COMBINATION
Emna Gharbi, Syrine Bellakhal, Zeineb Meddeb, Maroua Mrouki, Istabrak Abdelkafi, Mohamed Hedi Douggui
P-0291 MULTIPLE MYELOMA AND THROMBOSIS
Elif Umit, Ahmet Muzaffer Demir
P-0315 MANAGEMENT OF VENOUS THROMBOEMBOLISM IN CHILDREN IN A
SINGLE-PEDIATRIC TERTIARY CARE MEDICAL CENTER.
Flor Yus Cebrian, Carmen Coello De Portugal, Nuria Fernandez-Mosteirin, Marcio Andrade, Jose Manuel Calvo Villas
P-0185 UPPER LIMBS VENOUS THROMBOSES: A STUDY OF 32 CASES
Hana Zoubeidi, Thouraya Ben Salem, Cherifa Abdelkafi, Imed Ben
Ghorbel, Monia Khanfir, Mounir Lamloum, Mohamed Habib Houman
P-0322 PARTICULARITIES OF PULMONARY EMBOLISM: AN INTERNAL MEDICINE DEPARTMENT EXPERIENCE
Emna Gharbi, Syrine Bellakhal, Badreddine Ben Kaab, Akil Mestiri,
Mohamed Hedi Douggui
P-0191 VENA CAVA THROMBOSES: A STUDY OF CLINICAL AND ETIOLOGICAL
FEATURES OF 42 CASES
Ines Naceur, Thouraya Ben Salem, Molka Togourti, Imed Ben Ghorbel,
Monia Khanfir, Mounir Lamloum, Mohamed Habib Houman
P-0354 PLASMA TOTAL HOMOCYSTEINE LEVELS AND OTHER BIOCHEMICAL
PARAMETERS IN ALGERIAN PATIENTS WITH DEEP VEIN THROMBOSIS
Amrane Mounira, Kheira Boussouf, Zahira Houcher, Samia Begag,
Bakhouche Houcher, Abderrezak Touabti
P-0366 SELECTION OF BIOLOGICAL MARKERS OF HYPERCOAGULABILITY
FOR THE IDENTIFICATION OF HIGH VTE RISK PATIENTS WITH LUNG
ADENOCARCINOMA. THE ROADMAP STUDY
I. Evmorfiadis, P. Boura, A. Rousseau, A. Charpidou, G. Giozos, P. Van
Dreden, K. Syrigos, A. Larsen, Ismail Elalamy, G. T. Gerotziafas
P-0367 A NEW RISK ASSESSMENT MODEL FOR VTE IN AMBULATORY PATIENTS WITH LUNG ADENOCARCINOMA ON CHEMOTHERAPY. THE
ROADMAP STUDY
Gerotziafas G, Evmorfiadis I, Boura P, Giozos G, Charpidou A, Rousseau A, Van Dreden P, Grusse M, Annette Larsen, Syrigos K, Ismail
Elalamy
Diagnostic and laboratory
methods
P-0070 DISTRIBUTION OF PLATELET AND PLATELET INDICES DUE TO AGE
Yasemin Ardicoglu Akisin, Mehmet Nejat Akar
P-0089 EVALUATION OF VITAMIN K ANTAGONISTS ANTICOAGULATION EFFECT
Tatjana Makarovska-Bojadzieva, Velkova Emilija, Milenka Blagoevska,
Julija Samonikov Tosevska, Violeta Dejanova Ilijevska, Jasminka Nikolova Diagnostic and laboratory methods
P-0093 THE ROLE OF PLATELET-TO-LYMPHOCYTE RATIO IN THE DIAGNOSIS
OF INFECTIOUS MONONUCLEOSIS
Zeynep Nur Karagoz, Yasemin Ardicoglu Akisin, Mustafa Turan, Mehmet Nejat Akar
P-0154 ANTIBODIES TO FACTOR XII DIAGNOSED AT THE TIME OF LABOR
FOLLOWING VARICELLA INFECTION DURING PREGNANCY: A CASE
REPORT
Sassi Mouna, Abderrazak Fatma, Baccouche Héla, Zrelli Amira, Chatti
Najla, Hassine Mohsen, Babba Hamouda
P-0157 THROMBOPHILIA ASSESSMENT IN PATENTS WITH VENOUS THROMBOEMBOLISM
Tatjana Makarovska-Bojadzieva, Emilija Velkova, Milenka Blagoevska,
Julija Samonikov Tosevska, Anita Hristova Dimceva
P-0207 REVIEW OF D-DIMER PROFICIENCY TESTING DATA WITH RESPECT TO
DIFFERENT CONTROL SAMPLE TYPE
Jasna Lenicek Krleza, Ana Bronic
Disseminated
Intravascular coagulation
P-0227 GASTRIC DENOCARCINOMA WITH BONE MARROW CARCINOMATOSIS COMPLICATED WITH CANCER RELATED THROMBOTIC MICROANGHIOPATHY
Semih Gulle
P-0311 THERAPEUTIC PLASMA EXCHANGE FOR THROMBOTIC MICROANGIOPATHY
Erden Atilla, Pinar Ataca, Ugur Sahin, Sinem Civriz Bozdag, Selami
Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan,
Taner Demirer, Muhit Ozcan, Hamdi Akan, Meral Beksac, Gunhan
Gurman, Osman Ilhan
P-0369 COMPARISON OF THE COAGULATION ABNORMALITIES IN PATIENTS
WITH DIC COMPARED TO WARFARINIZED PATIENTS
Jawed Fareed, Amanda Walborn Daniel Kahn, Mark Williams, Debra
Hoppensteadt
Fibrinogen and other
coagulation factors
P-0131 A HEMOPHILIA CASE WHO ‘S DIAGNOSED LYMPHOMA AND TREATED WITH CHEMOTHERAPY
Handan Sahin, Vahap Okan Okan, Mehmet Yilmaz, Mustafa Pehlivan,
Ibrahim Sari, Ali Caner Ozdover
P-0179AN ACQUIRED FVII DEFICIENCY AND HYPOFIBRINOGENAEMIA
FOLLOWING AN HEMATOPOIETIC STEM CELL TRANSPLANTATION
Hela Baccouche, Amel Lakhal, Sonia Mahjoub, Aya Chakroun, Tarek
Ben Othman, Neila Ben Romdhane
P-0313 ACQUIRED DEFICIENCY OF VITAMIN K-DEPENDANT CLOTTING FACTORS, DESCRIPTIVE REPORT OF 3 CASES, SINGLE CENTRE EXPERIENCE
Isil Erdogan Ozunal, Ayse Salihoglu, Nurgul Ozgur Yurttas, Dilek Keskin, Sevil Sadri, Selin Berk, Fevzi Firat Yalniz, Ahmet Emre Eskazan,
Seniz Ongoren, Teoman Soysal, Yildiz Aydin, Zafer Baslar, Muhlis Cem
Ar
P-0314 HYPOFIBRINOGENEMIA; DESCRIPTIVE REPORT OF 5 CASES, SINGLE
CENTRE EXPERIENCE
Ece Vural, Isil Erdogan Ozunal, Ayse Salihoglu, Nurgul Ozgur Yurttas,
Dilek Keskin, Sevil Sadri, Selin Berk, Fevzi Firat Yalniz, Tugrul Elverdi,
Ahmet Emre Eskazan, Muhlis Cem Ar, Seniz Ongoren, Teoman Soysal,
Yildiz Aydin, Zafer Baslar
D
T
L
P-0221 SHORT EVALUATION OF FIBRINOGEN DETERMINATION BY DADE
THROMBIN REAGENT ON SYSMEX CA 1500 ANALYSER
Ana Bronic, Marina Pavic
P-0222 COAGULATION LABORATORY NETWORK IN REPUBLIC OF CROATIA
Ana Bronic, Desiree Coen Herak, Sandra Margetic, Marija Milic
M
E
P-0260 RETROSPECTIVE EVALUATION OF PATIENTS WITH FACTOR XI DEFICIENCY: RESULTS FROM A SINGLE CENTRE
Sevil Sadri, Isil Erdogan Ozunal, Selin Berk, Dilek Keskin, Nurgul
Ozgur Yurttas, Ayse Salihoglu, Ahmet Emre Eskazan, Seniz Ongoren,
Muhlis Cem Ar, Teoman Soysal, Zafer Baslar
P-0274 ASSOCIATIONS BETWEEN COMPLETE BLOOD COUNT RESULTS AND
D- DIMER LEVEL IN PATIENTS WITH ARTERIAL OR VENOUS THROMBOSIS
Zuhre Kaya
P-0320 HEMOPHILIA: A SINGLE-CENTRE EXPERIENCE OF 12 YEARS
Hande Kizilocak, Gül Nihal Ozdemir, Gürcan Dikme, Begüm Koc, Tiraje
Celkan
Fibrinolysis and
thrombolysis
P-0051 EFFECT OF ANTIHYPERTENSIVE DRUGS ON THE ACTIVITY OF PROTEASES OF THE FIBRINOLYTIC SYSTEM IN VITRO
Roza Aisina, Lilia Mukhametova, Karina Gershkovich, Sergei Varfolomeyev
Genetics and genomics
in thrombosis and
Hemostasis
P-0102 SCREENING OF EPCR VARIANTS AND THEIR CORRELATION WITH
FACTOR V LEIDEN AND PROTHROMBIN 20210A MUTATIONS IN
TURKISH PEDIATRIC PATIENTS WITH ACUTE LEUKEMIA
Dilara Fatma Akin, Deniz Aslar Oner, Kadir Sipahi, Mine Mumcuoglu,
Emin Kurekci, Ustun Ezer, Nejat Akar
P-0106 THE ASSOCIATION OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1
(PAI-1) 4G/5G POLYMORPHISM AND FACTOR V LEIDEN (FVL) MUTATION IN PEDIATRIC ACUTE LEUKEMIA PATIENTS
Dilara Fatma Akin, Deniz Aslar Oner, Mine Mumcuoglu, Emin Kurekci,
Ustun Ezer, Nejat Akar
P-0169 ASSOCIATION OF MDR1 C3435T AND G2677T/A POLYMORPHISMS
WITH PLASMA PLATELET ACTIVATING FACTOR LEVELS AND ADP-INDUCED PLATELET FUNCTIONS IN CORONARY ARTERY DISEASE PATIENTS
Turgut Ulutin, Gulsel Ersoy Ayaz, Bahadir Batar, Gonul Kanigur, Mehmet Guven, Ilhan Onaran, Bilgehan Karadag, Baris Ilerigelen, Ahmet
Dirican
P-0182 FIRST OBSERVATION OF TUBB1 GENE MUTATIONS IN TURKISH PATIENTS WITH MACROTHROMBOCYTOPENIA
Didem Torun Ozkan, Abdullah Abdul Waheed, Ayten Kandilci, Nejat
Akar
P-0194 ASSOCIATION OF CANDIDATE GENES POLYMORPHISM WITH
PLATELET FUNCTION AND CARDIOVASCULAR EVENTS ZAPROVALNA O. SI “L.T.MALAYA THERAPY INSTITUTE NAMSU”, KHARKIV,
UKRAINE
Olga Zaprovalna
P-0205 RELATIONSHIP BETWEEN ACROMEGALY AND GROWTH ARREST-SPECIFIC GENE 6
Fikriye Uras, Nihan Verimli, Ozlem Bingol Ozakpinar, Dilek Yavuz Gogas
P-0265 MTHFR C677T POLYMORPHISM AND THROMBOTIC COMPLICATIONS
IN SICKLE CELL DISEASE PATIENTS
Iakovos Armenis, Vasiliki Kalotychou, Zoe Kontogeorgiou, Reveka
Tzanetea, Konstantinos Pantos, Konstantinos Konstantopoulos, Ioannis Rombos
P-0351 CUTANEOUS NECROSIS REVEALING PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA. A NEW CASE
Tazi Mezalek Zoubida, Bouigua Nisrine, Harmouche Hicham, Bourkia
Meriem, Mounfaloti Wafaa, Ammouri Wafaa, Maamar Mouna, Adnaoui Mohamed
P-0357 THE EFFECT OF TMRPSS6 (RS2235324, RS855791, RS2111833)
POLYMORPHISMS ON RED BLOOD CELL LEVELS IN IRON DEFICIENCY ANAEMIA
Tuba Mutlu, Serap Yavuzer, Isil Bavunoglu, Mahir Cengiz, Hakan Yavuzer, Yusuf Ziya Erzin, Aydin Tunckale, Meltem Mete, Mehmet Guven
Hemostasis and
inflammation
P-0292 SUPERFICIAL VENOUS THROMBOSIS: A SERIOUS CONDITION
Emna Gharbi, Syrine Bellakhal, Badreddine Ben Kaab, Akil Mestiri,
Mohamed Hedi Douggui
P-0334 PROMPT DIAGNOSE AND TREATMENT OF ACQUIRED HEMOPHILIA A:
A CASE REPORT
Filipe Vasconcelos, Manuela Carvalho, Luciana Goncalves Ricca, David Aranda, Carmo Koch
P-0344 THROMBOSIS IN PAROXYSMAL NOCTURNAL HEMOGLOBULINURIA
PATIENTS: SINGLE CENTER EXPERIENCE
Mustafa Merter, Ugur Sahin, Mehmet Gunduz, Zehra Narli Ozdemir,
Sinem Civriz Bozdag, Selami Kocak Toprak, Pervin Topcuoglu, Onder
Arslan, Muhit Ozcan, Osman Ilhan, Meral Beksac, Hamdi Akan, Gunhan Gurman, Meltem Kurt Yuksel
Hemostasis, Thrombosis
and malignancy
P-0376 INFLAMMATION AND HEMOSTATIC ACTIVATION MAY CONTRIBUTE TO
POSTSURGICAL THROMBOSIS IN PATIENTS WITH BLADDER CANCER
Schuharazad Abro, Melanie Clark, Guliz Barkan, Debra Hoppensteadt,
Jawed Fareed, Eva Wojick, Marcus Quek
Heparins and heparin
induced thrombocytopenia
P-0319 DABIGATRAN USE FOR MANAGEMENT OF HEPARIN-INDUCED
THROMBOCYTOPENIA IN A PATIENT WITH CANCER-RELATED
THROMBOSIS
Luciana Goncalves Ricca, Manuela Carvalho, Ana Leite, Gabriela Fernandes, Filipe Vasconcelos, Carmo Koch
M
E
Lupus anticoagulant/
Phospholipid dependent
antibodies
P-0150 THROMBOSES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
Thouraya Ben Salem, Ines Naceur, Cherifa Abdelkafi, Imed Ben Ghorbel, Mounir Lamloum, Mohamed Habib Houman
P-0178 ANTIPHOSPHOLIPID ANTIBODIES IN MYELOPROLIFERATIVE DISEASE:
RELATIONSHIP WITH JAK2 V617F STATUS AND THROMBOTIC PROFILE
Hela Baccouche, Montaha Ben Jemaa, Aya Chakroun, Sonia Mahjoub,
Houria Lahmar, Lilia Laadhar, Mariam Sallami, Neila Ben Romdhane
P-0251 ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH IMMUNE
THROMBOCYTOPENIC PURPURA
Sahika Sahinkaya, Huseyin Tokgoz, Umran Caliskan
P-0256 MPL W515 K MUTATION IN A PEDIATRIC CASE OF ESSENTIAL
THROMBOCYTHEMIA PRESENTING WITH BUDD-CHIARI SYNDROME
Huseyin Tokgoz, Umran Caliskan, Reyhan Kucukkaya, Veysel Sabri
Hancer
P-0264 BONE MARROW NECROSIS AND PULMONARY THROMBOSIS ASSOCIATED WITH ANTIPHOSPHOLIPID SYNDROME
Huseyin Tokgoz, Umran Caliskan
P-0296 A CASE OF AN ANTITHROMBIN DEFICIENCY WITH MESENTERIC
THROMBOSES AND CEREBRAL INFARCT
Tugcan Alp, Vldan Ozkocaman, Fahr Ozkalemkas, Cemle Sanl, Hlm
Erdem Gozden, Zafer Serenl Yegen, Rdvan Al
P-0298 MULTIPLE TROMBOSES, HEMOLYTIC ANEMIA; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME, A CASE REPORT
Tugcan Alp, Srn Zelal Trnova, Hlm Erdem Gozden, Tuba Ersal, Fahr
Ozkalemkas, Vldan Ozkocaman, Rdvan Al
Microparticles
P-0195 DR. TUBA HILKAY KARAPINAR
Burcak Tatli Gunes, Meral Turker, Salih Gozmen, Yilmaz Ay, Berna Atabay, Yesim Oymak, Dilek Ince, Tuba Hilkay Karapinar, Gulcihan Ozek,
Canan Vergin
P-0210 PHOSPHOLIPID DEPENDENT PROCOAGULANT ACTIVITY EXPRESSED
BY CIRCULATING MICROPARTICULES IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS
Hela Baccouche, Montaha Ben Jemaa, Sonia Mahjoub, Aya Chakroun, Zeineb Manai, Neila Ben Romdhane
Perinatal and pediatric
hemostasis
P-0119 THE ASSESSMENT OF PROTHROMBOTIC POTENTIAL USING THROMBIN GENERATION ASSAY IN PATIENTS WITH NEPHROTIC SYNDROME
IN CHILDHOOD
Eren Soyaltin, Yilmaz Ay, Yilmaz Ay, Erkin Serdaroglu, Yesim Oymak,
Tuba Hilkay Karapinar, Canan Vergin
P-0247 INHERITED PROTHROMBOTIC RISK FACTORS IN MOTHER-CHILD
PAIRS AND PERINATAL STROKE
Jasna Lenicek Krleza, Ana Grzunov, Desiree Coen Herak, Vlasta Duranovic, Renata Zadro
P-0249 IMPACT OF AGE ON GENERAL FEATURES OF PATIENTS WITH IMMUNE
THROMBOCYTOPENIA IN TRAKYA REGION, TURKEY
Elif Umit, Ahmet Muzaffer Demir
P-0282 THE IMPORTANCE OF OXIDATIVE STRESS IN ABNORMALITIES OF
PLATELET FUNCTION. THE RETROSPECTIVE STUDY IN CHRONIC MYELOID LEUKEMIA AND MYELODISPLASTIC SYNDROME PATIENTS
Viola Maria Popov, Maria Minodora Iordache, Eugenia Kovacs, Mihaela Georgeta Moisescu, Mihaela Tevet, Ana Maria Vladareanu, Horia
Bumbea, Meilin Murat, Tudor Savopol
P-0307 IBRUTINIB AND AGGREGATION
Juraj Sokol, Juraj Chudej, Ingrid Skornova, Lukas Duraj, Matej Hrncar,
Andrej Rosik, Peter Kubisz, Jan Stasko
P-0323 THERAPEUTIC THROMBOCYTAPHERESIS: HIGHER PLATELET COUNTS
SHOULD MATTER
Zehra Narli, Ugur Sahin, Sinem Civriz Bozdag, Meltem Kurt Yuksel,
Selami Kocak Toprak, Pervin Topcuoglu, Muhit Ozcan, Onder Arslan,
Taner Demirer, Meral Beksac, Gunhan Gurman, Osman Ilhan
Pregnancy and thrombosis
P-0297 THE ROLE OF T CELLS AND SOME CYTOKINS IN ENDOMETRIAL TISSUE IN UNEXPLAINED INFERTILITY
Enver Ciraci, Sadik Sahin, Sevgin Degirmencioglu, Dilsad Herkiloglu,
Bulent Tekin, Tayfun Unal, Sermin Tetik
P-0341 A CASE OF OBSTRETRIC CEREBRAL VENOUS SINUS THROMBOSIS:
CT AND MRI FINDINGS
Triantafyllou Evaggelia, Papaevangelou Angeliki, Pithara Christala, Mihalopoulou Anna, Papaioannou Dimitrios, Stefanoglou Nikolaos
Regenerative medicine and
tissue engineering
P-0202 GROWTH ARREST-SPECIFIC 6 PROTEIN AFFECTS DIFFERENTIATION
OF MESENCHYMAL STEM CELLS INTO OSTEOGENIC, CHONDROGENIC AND ADIPOGENIC CELLS
Fikriye Uras, Nese Eriz, Ozlem Bingol Ozakpinar, Naziye Ozkan
D
T
L
P-0276 LONG-TERM FOLLOW-UP OF TWO CHILDREN WITH RECURRENT IMMUNE THROMBOCYTOPENIC PURPURA
Zuhre Kaya
M
E
Platelets and
Megakaryocytes
P-0215 INVESTIGATION OF CLINICAL SIGNIFICANCE OF PLATELET DYSFUNCTION IN PATIENTS WITH THROMBOCYTOPENIA
Mehmet Can Ugur, Fatma Demet Ince, Cengiz Ceylan, Harun Akar,
Kaan Kavakli
Surgery: Hemostasis and
Thrombosis
P-0044 NEW HAEMOSTATIC DRUG BASED ON A SYNTHETIC TRIPEPTIDE INHIBITOR OF PLASMIN
Lilia Mukhametova, Roza Aisina, Tatiana Voyushina, Sergei Varfolomeyev, Sergei Yarotsky
EXHIBITOR FLOOR PLAN
FENER
AUDITORIUM
TOPHANE
AUDITORIUM
17
15 16
EYUP
AUDITORIUM
20
21
22
23
24
10 12
9 14
EXHIBITION
AREA
REGISTRATION DESK
POSTERS AREA
stand nº 9-10
stand nº 12
stand nº 14
stand nº 20
stand nº 21
stand nº 22
M
E
stand nº 15-16
stand nº 17
stand nº 23
stand nº 24
Special prepublication offer:
CHF 75.00 / EUR 70.00 / USD 88.00
SickKids Handbook
of Pediatric Thrombosis
and Hemostasis
Coming soon!
2nd, revised edition
Editors
Victor S. Blanchette
Leonardo R. Brandão
Vicky R. Breakey
Shoshana Revel-Vilk
This updated edition of the SickKids Handbook takes the reader through the entire field of
pediatric thrombosis and hemostasis.
An introductory section concisely explains the complex pathophysiology of hemostasis and
thrombosis. The chapters that follow include practical, evidence-based information on the
diagnosis and management of inherited and acquired bleeding disorders and thrombotic
events of the venous, arterial, cardiac and central nervous systems that affect children.
Special features include practical clinical algorithms and appendices that cite normal laboratory reference ranges, as well as recommended dosages of blood products and major hemostatic agents. A stand-alone chapter is dedicated to developmental hemostasis and bleeding in the neonate. A chapter on antithrombotic therapy in children gives succinct
information on the old and new anticoagulants, antiplatelet drugs and thrombolytic agents.
Written and reviewed by international experts in the field, this handbook is intended for
health care professionals involved in the assessment and care of children with inherited and
acquired bleeding and clotting disorders, including general and specialist pediatricians (in
particular intensivists, neonatologists, cardiologists/cardiac surgeons, rheumatologists and
nephrologists), hematologists/oncologists (pediatric and adult), as well as medical trainees,
nurses, nurse practitioners and pharmacists.
Review from the first edition:
I recommend the handbook to all paediatricians treating children with bleeding and thromboembolic disorders. This is a book we have been waiting for. At our ward, we found the recommendations we needed to work out femoral artery thrombosis, anticoagulation in cardiomyopathy and
investigation of bleeding disorders by reading this handbook.
Ellen Ruud, Acta Paediatrica, Vol. 103, No. 1, 2014
Fields of Interest; Hematology, Cardiology,
Intensive Care, Neonatology, Neurology,
Nursing, Oncology, Pediatrics, Pharmacology
Order Form
SickKids Handbook of
Pediatric Thrombosis and Hemostasis
2nd, revised edition
Editors: V.S. Blanchette; L.R. Brandão
(Toronto, Ont.); V.R. Breakey (Hamilton, Ont.);
S. Revel-Vilk (Jerusalem)
approx. XV + 279 p., 23 fig., 59 tab.,
soft cover, 2016
Special prepublication price:
CHF 75.00 / EUR 70.00 / USD 88.00
Prices subject to change, VAT not included
EUR price for eurozone countries,
USD price for USA and Latin America only
ISBN 978–3–318–03026–6 (soft cover)
e-ISBN 978–3–318–03027–3
w w w.karger.com/sick k ids
Please send:
Name/Address:
Postage and handling free with prepayment
Payment:
Please charge to my credit card
American Express Diners
MasterCard
Visa
M
E
Card No.:
Exp. date:
CVV/CVC
(3 digits in the signature field on the back of Visa and MasterCard)
Check enclosed
Please bill me
Karger – Medical and Scientific Publishers
CH–4009 Basel, Switzerland
[email protected], f: +41 61 306 12 34
www.karger.com
24KI16309p
D
T
L
copy/ies
Date:
Signature:
Volumes 115 and 116 in 2016
6 issues per volume | ISSN 0340-6245
Today’s Science for Tomorrow’s Results
Thrombosis and Haemostasis is the official Organ of the Working
Groups "Thrombosis" and "Atherosclerosis and Vascular Biology" of
the European Society of Cardiology (ESC), the Sociedad Española
de Trombosis y Hemostasia (SETH), the Australian Vascular Biology
Society (AVBS) and the Gesellschaft für Thrombose- und Hämostaseforschung (GTH).
Impact Factor
2014: 4.984!
Thrombosis and Haemostasis
publishes original contributions of basic and original
research and clinical studies in vascular biology and
medicine, serving as an international platform for the
dissemination and debate of scientific information. The
Journal appears monthly in both print and online.
Visit our homepage and register for eTOC today at:
www.thrombosis-online.com
ORDER NOW:
FAX ORDER: +49 711 22987-85
E-MAIL: [email protected]
Street / P.O. Box
City / state / ZIP code
Country
Phone / fax / e-mail
Date / signature
All prices are subject to change without notice
T
L
M
E
Subscription Rates – Print and Online:
Thrombosis and Haemostasis
2016. Volume 115 and 116 (6 issues per volume)
 Institutes
First name / last name
Subscribers to and readers of Thrombosis and Haemostasis enjoy
• A reliable publication platform in vascular biology and medicine
• Renowned authors – leaders in their field of research
• Electronic Table of Contents – register online today!
• Online submission and TH First: epub ahead of print
• A broad scope covering expanded areas of interest including:
- Coagulation and Fibrinolysis
- Cellular Haemostasis and Platelets
- Blood Cells, Inflammation and Infection
- Endothelium and Angiogenesis
- Cellular Signalling and Proteolysis
- New Technologies, Diagnostic Tools and Drugs
- Stroke, Systemic or Venous Thromboembolism
- Atherosclerosis and Ischaemic Disease
€ 1132.001
 Individuals
€ 456.001
 Members ESC, ISTH, AVBS
€ 228.001
1
EU: Mailing costs included. Our subscriptions are Media-Subscriptions (print + online), for which the subscription price is divided into 90 % representing the print content
and 10 % representing the online content. For orders delivered within the European
Union, 7 % VAT for the print content and the applicable VAT rate depending on country
of destination for the online content will be added to the subscription price.
Overseas: As above plus mailing costs € 48.00
Payment:
 Please bill me
 Please charge my credit card
 Visa  MasterCard
Card number
Expiration date
Card authorisation number
I hereby authorise you to invoice me as above.
Please enter my subscription starting with month: _____
Cancellation Policy: The Journal and the invoice will be sent directly by the
Publisher Schattauer GmbH, Hoelderlinstrasse 3, 70174 Stuttgart, Germany,
CEO Dieter Bergemann, Dipl.-Psych. Dr. med. Wulf Bertram, Jan Haaf,
Court of Registration Stuttgart HRB 3357. Orders can be cancelled within
14 days. Cancellations are accepted from date of postage. Any cancellation
must, however, be made in writing by post, email or fax. The subscription
will be automatically renewed, unless cancellation notice is received by
September 30th.
Date / 2nd signature
 I agree to receiving info material and newsletters by mail or e-mail from
Schattauer Publishers. I can cancel this at any time by sending an e-mail to
[email protected]. My data are collected in accordance with current German
data privacy protection laws.
25
Biennial
international
Congress
on thromBosis
23-26 May, 2018
Palazzo del Cinema - Venice Convention Center
Venice, Italy
26
D
T
L
M
E
SPONSORS
OFFICIAL JOURNAL
T
L
M
E
MEDIA PARTNERS
27
EMLTD
M
E
D
T
L
Technical Secretariat
GESTIÓN DE CONGRESOS Y SOCIEDADES
www.geyseco.es
Phone (+34) 963511632 Fax (+34) 963942558
[email protected]
T
L

Programme - 24th Biennial International Congress on

Transkript

Benzer belgeler

A Case of Deep Vein Thrombosis in the Postpartum Period

18-Jan-2013 - Montana State University

corporate golf day packages 2 - Mount Edgecombe Country Club